TP63 ‐rearranged ALK ‐negative anaplastic large‐cell lymphoma post‐transplant lymphoproliferative disorder: the first report of an aggressive entity

Documenti analoghi

• Incidence and outcomes of post‐transplant lymphoproliferative disorder in the Western Australian liver transplant population: a 24‐year retrospective study
  di: Rohita Reji, et al.
  Pubblicazione: (2025)
• Management of patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplantation: position statement of the Medical and Scientific Advisory Group of Myeloma Australia
  di: Georgia McCaughan, et al.
  Pubblicazione: (2025)
• Treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group
  di: Shirlene Sim, et al.
  Pubblicazione: (2026)
• Feasibility and outcomes of kidney transplantation in patients with end‐stage kidney disease after haemopoietic stem cell transplantation
  di: Bioh Kim, et al.
  Pubblicazione: (2026)
• A large long‐term database of Gaucher disease patients demonstrates increased risk of lymphoma and myeloma, but not of solid tumours
  di: Majdolen Istaiti, et al.
  Pubblicazione: (2025)